CR20110070A - Notch fixing agents and antagonists and methods for their use - Google Patents
Notch fixing agents and antagonists and methods for their useInfo
- Publication number
- CR20110070A CR20110070A CR20110070A CR20110070A CR20110070A CR 20110070 A CR20110070 A CR 20110070A CR 20110070 A CR20110070 A CR 20110070A CR 20110070 A CR20110070 A CR 20110070A CR 20110070 A CR20110070 A CR 20110070A
- Authority
- CR
- Costa Rica
- Prior art keywords
- antagonists
- methods
- notch
- fixing agents
- notch fixing
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
El presente invento se relaciona con agentes fijadores de Notch y antagonistas de la proteína Notch y métodos para el uso de los agentes y/o antagonistas para el tratamiento de enfermedades como el cáncer. El presente invento suministra anticuerpos los cuales se fijan de manera específica a una región no fijadora de ligandos del dominio extracelular de uno o más receptores Notch humanos, como Notch2 y/o Notch3, e inhiben el crecimiento tumoral.The present invention relates to Notch fixing agents and Notch protein antagonists and methods for the use of agents and / or antagonists for the treatment of diseases such as cancer. The present invention provides antibodies which specifically bind to a non-binding region of extracellular domain ligands of one or more human Notch receptors, such as Notch2 and / or Notch3, and inhibit tumor growth.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CR20110070A CR20110070A (en) | 2011-02-07 | 2011-02-07 | Notch fixing agents and antagonists and methods for their use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CR20110070A CR20110070A (en) | 2011-02-07 | 2011-02-07 | Notch fixing agents and antagonists and methods for their use |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20110070A true CR20110070A (en) | 2011-07-11 |
Family
ID=44996361
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20110070A CR20110070A (en) | 2011-02-07 | 2011-02-07 | Notch fixing agents and antagonists and methods for their use |
Country Status (1)
Country | Link |
---|---|
CR (1) | CR20110070A (en) |
-
2011
- 2011-02-07 CR CR20110070A patent/CR20110070A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2011000004A (en) | NOTCH FIXING AGENTS AND ANTAGONISTS AND METHODS FOR THE USE OF THE SAME | |
CY1121148T1 (en) | VEGF / DLL4 CONNECTING FACTORS AND THEIR USES | |
CR20140146A (en) | ANTI-BODIES ANTI-CD134 (OX40) AND USES OF THE SAME | |
CL2016002359A1 (en) | Antibodies that bind to human epidermal growth receptor (anti-egfr) and anti-egfr antibody and drug conjugates | |
EA201391507A1 (en) | ANTIBODIES AGAINST c-Kit AND THEIR APPLICATION | |
BR112017006825A2 (en) | antibodies to glucocorticoid-induced tumor necrosis factor receptor (gitr) and their methods of use | |
UA107827C2 (en) | Antibody cd40 | |
CR20130126A (en) | ANTI-OX40 ANTIBODIES AND METHODS OF USE OF THE SAME | |
EA201500314A1 (en) | DOSAGE FORMS OF ENZALUTAMIDE | |
BR112016018891A2 (en) | anti-dll3 antibodies and drug conjugates for use in melanoma | |
EA201490778A1 (en) | ANTIBODIES AGAINST HtrA1 AND METHODS OF APPLICATION | |
GT201300118A (en) | ESPIRO-OXINDOL MDM2 ANTAGONISTS | |
EA201590174A1 (en) | IMMUNOCONGATES CONTAINING ANTI-CD22 ANTIBODIES | |
AR088694A1 (en) | CYTOTOXIC PEPTIDES AND CONJUGATES OF ANTIBODY-PHARMACY OF THE SAME | |
PE20150360A1 (en) | HUMAN R-SPONDINE PROTEIN BINDING AGENTS (RSP03) AND USES OF THEM | |
UY34885A (en) | ANTI-MESOTHELINE UNION PROTEINS | |
EA201400178A1 (en) | BREAST CANCER TREATMENT | |
CR20130517A (en) | COMBINED TREATMENTS FOR MALIGNAS HEMATOLOGICAL NEOPLASIAS | |
EA201391248A1 (en) | BISPECIFIC BINDING AGENTS | |
EA201491357A1 (en) | ANTI-LRP5 ANTIBODIES AND METHODS OF THEIR APPLICATION | |
BR112018000254A2 (en) | pde9 inhibitors with imidazotriazinone main chain and imidazopyrazinone main chain for the treatment of peripheral diseases | |
BR112013022882A2 (en) | use of egfr family receptor inhibitors in the treatment of hormone-refractory breast cancers | |
EA201790529A1 (en) | NEW ANTIBODIES AGAINST MFI2 AND METHODS OF THEIR APPLICATION | |
UY35136A (en) | METHODS TO TREAT OVARY CANCER WITH DLL4 ANTAGONISTS. | |
EA201400339A1 (en) | NEW IMIDAZOLAMINES AS MODULATORS OF KYNASE ACTIVITY |